* Price reflects a 6-month treatment plan. For research purposes only.
1
Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans, 2013
Across six randomized, double-blind, placebo-controlled trials, AOD-9604 showed a safety profile indistinguishable from placebo with no adverse effects on IGF-1, glucose tolerance, or insulin resistance.
Connect instantly with a provider anytime, day or night. No appointments, no waiting.
Non-Hormonal & Non-Stimulant
Supports metabolic health without hormone disruption or stimulant effects.
Focused on Body Composition
Promotes gradual fat-utilization for balanced weight management.
Clinically Well-Tolerated
Multiple studies confirm excellent safety and tolerability in humans.
Frequently asked questions
What is BioBylt Labs?
SS-31 and NAD+ target aging mitochondria through two different mechanisms. Here is why combining them produces results that neither compound achieves on its own.
What is BioBylt Labs?
SS-31 and NAD+ target aging mitochondria through two different mechanisms. Here is why combining them produces results that neither compound achieves on its own.
Your body already holds the blueprint — AIRA helps you unlock it. Our physician-guided peptide programs will help you perform, recover, and feel your best.